ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer

Clinical trial NCT01009788 · COMPLETED

Trial details

NCT number: NCT01009788
Sponsor: Steven J Isakoff, MD, PhD
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastatic Breast Cancer BRCA1 Gene Mutation brca2 Gene Mutation

Start date: 2009-11-01
Primary completion: 2012-09-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.